NCT04250207: A reported trial by Kowa Research Institute, Inc.
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT04250207 |
|---|---|
| Title | A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12 Week, Phase 2 Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Patients With Fuchs Endothelial Corneal Dystrophy |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 23, 2020 |
| Completion date | Sept. 22, 2021 |
| Required reporting date | Sept. 22, 2024, midnight |
| Actual reporting date | Sept. 20, 2024 |
| Date last checked at ClinicalTrials.gov | June 3, 2026 |
| Days late | None |